Blanco J, Trinite B, Puig-Barbera J
Influenza Other Respir Viruses. 2025; 19(1):e70076.
PMID: 39871737
PMC: 11773156.
DOI: 10.1111/irv.70076.
Smith C, Hartman R, Kugler A, Little V, Baker O, Fairlie T
Viruses. 2024; 16(10).
PMID: 39459907
PMC: 11512241.
DOI: 10.3390/v16101573.
McCulloch L, Mouat I, South K, McColl B, Allan S, Smith C
Discov Immunol. 2024; 1(1):kyac004.
PMID: 38566903
PMC: 10917238.
DOI: 10.1093/discim/kyac004.
Abbad A, Yellin T, Singh G, Fried M, Raskin A, Tcheou J
Cell Rep Med. 2024; 5(3):101474.
PMID: 38508136
PMC: 10983110.
DOI: 10.1016/j.xcrm.2024.101474.
Kiselev I, Akberdin I, Kolpakov F
Sci Rep. 2023; 13(1):13439.
PMID: 37596296
PMC: 10439236.
DOI: 10.1038/s41598-023-40008-9.
Balance between maternal antiviral response and placental transfer of protection in gestational SARS-CoV-2 infection.
Goncalves J, Melro M, Alenquer M, Araujo C, Castro-Neves J, Amaral-Silva D
JCI Insight. 2023; 8(17).
PMID: 37490342
PMC: 10544212.
DOI: 10.1172/jci.insight.167140.
Assessment of Broadly Reactive Responses in Patients With MERS-CoV Infection and SARS-CoV-2 Vaccination.
Zedan H, Smatti M, Thomas S, Nasrallah G, Afifi N, Ait Hssain A
JAMA Netw Open. 2023; 6(6):e2319222.
PMID: 37389876
PMC: 10314312.
DOI: 10.1001/jamanetworkopen.2023.19222.
T-cell immunity to SARS-CoV-2: what if the known best is not the optimal course for the long run? Adapting to evolving targets.
Nowill A, Caruso M, de Campos-Lima P
Front Immunol. 2023; 14:1133225.
PMID: 37388738
PMC: 10303130.
DOI: 10.3389/fimmu.2023.1133225.
Antibody responses to Sinopharm/BBIBP-CorV in pregnant mothers in Sri Lanka.
Jeewandara C, Jayampathi K, Ranasinghe T, Aberathna I, Gunasekara B, Danasekara S
PLOS Glob Public Health. 2023; 2(7):e0000607.
PMID: 36962461
PMC: 10022122.
DOI: 10.1371/journal.pgph.0000607.
Subjects who developed SARS-CoV-2 specific IgM after vaccination show a longer humoral immunity and a lower frequency of infection.
Piubelli C, Ruggiero A, Calciano L, Mazzi C, Castilletti C, Tiberti N
EBioMedicine. 2023; 89:104471.
PMID: 36796232
PMC: 9925293.
DOI: 10.1016/j.ebiom.2023.104471.
Immunoglobulins response of COVID-19 patients, COVID-19 vaccine recipients, and random individuals.
Al-Tamimi M, Tarifi A, Qaqish A, Abbas M, Albalawi H, Abu-Raideh J
PLoS One. 2023; 18(2):e0281689.
PMID: 36787317
PMC: 9928079.
DOI: 10.1371/journal.pone.0281689.
Assessment of the longitudinal humoral response in non-hospitalized SARS-CoV-2-positive individuals at decentralized sites: Outcomes and concordance.
Djaileb A, Lavallee E, Parker M, Cayer M, Desautels F, de Grandmont M
Front Immunol. 2023; 13:1052424.
PMID: 36741379
PMC: 9895839.
DOI: 10.3389/fimmu.2022.1052424.
Longitudinal antibody titer, avidity, and neutralizing responses after SARS-CoV-2 infection.
Monroe J, Haralambieva I, Warner N, Grill D, Quach H, Kennedy R
Heliyon. 2022; 8(11):e11676.
PMID: 36439767
PMC: 9675084.
DOI: 10.1016/j.heliyon.2022.e11676.
Neutralizing Antibody Responses Among Residents and Staff of Long-Term Care Facilities in the State of New Jersey During the First Wave of the COVID-19 Pandemic.
Friedman S, Li J, Thomas P, Gurumurthy M, Siderits R, Nepomich A
J Community Health. 2022; 48(1):50-58.
PMID: 36197535
PMC: 9532818.
DOI: 10.1007/s10900-022-01142-z.
Kinetics of humoral immune response over 17 months of COVID-19 pandemic in a large cohort of healthcare workers in Spain: the ProHEpiC-19 study.
Violan C, Toran-Monserrat P, Quirant B, Lamonja-Vicente N, Carrasco-Ribelles L, Chacon C
BMC Infect Dis. 2022; 22(1):721.
PMID: 36057544
PMC: 9439943.
DOI: 10.1186/s12879-022-07696-6.
High SARS-CoV-2 Seroprevalence and Rapid Neutralizing Antibody Decline among Agricultural Workers in Rural Guatemala, June 2020-March 2021.
Iwamoto C, Lesteberg K, Lamb M, Calvimontes D, Guo K, Barrett B
Vaccines (Basel). 2022; 10(7).
PMID: 35891324
PMC: 9323551.
DOI: 10.3390/vaccines10071160.
Technical performance of a lateral flow immunoassay for detection of anti-SARS-CoV-2 IgG in the outpatient follow-up of non-severe cases and at different times after vaccination: comparison with enzyme and chemiluminescent immunoassays.
Barreira G, Dos Santos E, Badue Pereira M, Rodrigues K, Rocha M, Kanunfre K
Rev Inst Med Trop Sao Paulo. 2022; 64:e49.
PMID: 35858039
PMC: 9281580.
DOI: 10.1590/S1678-9946202264049.
Longitudinal Analysis of Coronavirus-Neutralizing Activity in COVID-19 Patients.
Hastert F, Henss L, von Rhein C, Gerbeth J, Wieters I, Borgans F
Viruses. 2022; 14(5).
PMID: 35632624
PMC: 9144377.
DOI: 10.3390/v14050882.
Interplay of infection and vaccination in long-term protection from COVID-19.
Tan H, Juno J
Lancet Infect Dis. 2022; 22(6):744-745.
PMID: 35366960
PMC: 8971275.
DOI: 10.1016/S1473-3099(22)00210-9.
SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals.
Ruggiero A, Piubelli C, Calciano L, Accordini S, Valenti M, Dalle Carbonare L
EBioMedicine. 2022; 77:103888.
PMID: 35196644
PMC: 8858081.
DOI: 10.1016/j.ebiom.2022.103888.